Brief: Alligator Says May Lay Off About 70% Of Current Workforce

Alligator Bioscience AB

02/12/2024 07:41

Dec 2 (Reuters) - Alligator Bioscience AB  ATORX.ST :
    * ALLIGATOR SHARPENS FOCUS ON MITAZALIMAB AND ANNOUNCES COST
REDUCTION PROGRAM TO MAXIMIZE LONG-TERM VALUE CREATION
    * EXPECTED ANNUAL CASH SAVINGS OF AT LEAST SEK 65 MILLION
    * PLANNED RESTRUCTURING MAY RESULT IN  REDUCTION OF ABOUT
70% OF
CURRENT WORKFORCE
    * RESTRUCTURING IS EXPECTED TO REDUCE OPERATIONAL COSTS BY
AT
LEAST SEK 65 MILLION ANNUALLY
    * WILL FOCUS ON LATE-STAGE DEVELOPMENT WITH AN ADEQUATE
WORKFORCE
OF APPROXIMATELY 15 FTES

Source text:  ID:nMFN63qp1g 
Further company coverage:  ATORX.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))